Sedana Medical AB (publ) (STO:SEDANA)

Market Cap	948.67M -8.7%
Revenue (ttm)	198.44M +0.4%
Net Income	-34.54M
EPS	-0.36
Shares Out	99.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,111
Open	9.16
Previous Close	9.30
Day's Range	9.16 - 9.55
52-Week Range	7.90 - 13.92
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 116
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2025, Sedana Medical AB's revenue was 200.23 million, an increase of 12.01% compared to the previous year's 178.75 million. Losses were -59.24 million, 455.0% more than in 2024.

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 4, 2026

Data Sources Report a data error